Reply
Najib Ben Khaled, Daniel Rössler, Florian P. Reiter, Julia Mayerle, Christian M. Lange, Max Seidensticker, Markus Guba, Enrico N. De Toni – 27 January 2022
Preliminary Evaluation of Atezolizumab Plus Bevacizumab as Salvage Treatment for Recurrent Hepatocellular Carcinoma After Liver Transplantation
Zhe Yang, Jingqi Sun, Li Zhuang, Haibo Mou, Shusen Zheng – 27 January 2022
The Patient Perspective on Telemedicine
Karen Hoyt, Andrew Reynolds – 27 January 2022
Introduction: The Role of Liver Transplantation in Acute‐on‐Chronic Liver Failure
Vinay Sundaram – 27 January 2022
Liver Transplantation in Mexico
Maximiliano Servin‐Rojas, Antonio Olivas‐Martinez, Liz Toapanta‐Yanchapaxi, Ignacio García‐Juárez – 27 January 2022
Nonalcoholic Fatty Liver Disease: The Role of Visceral Adipose Tissue
Courtney L. Hanlon, Liyun Yuan – 27 January 2022
Identifying the patient with acute‐on‐chronic liver failure: navigating through multiple definitions
Nikki Duong, Jasmohan Singh Bajaj – 27 January 2022
Liver Transplantation in Mexico
Maximiliano Servin‐Rojas, Antonio Olivas‐Martinez, Liz Toapanta‐Yanchapaxi, Ignacio García‐Juárez – 27 January 2022
Telemedicine and Health Disparities
Jennifer C. Price, Dinee C. Simpson – 27 January 2022